Computer-aided design of multi-target ligands at A1R, A2AR and PDE10A, key proteins in neurodegenerative diseases.

about

Computer-aided design of multi-target ligands at A1R, A2AR and PDE10A, key proteins in neurodegenerative diseases.

Item

http://www.wikidata.org/entity/Q47242194

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Computer-aided design of multi ...... in neurodegenerative diseases.

@en

Computer-aided design of multi ...... in neurodegenerative diseases.

@nl

type

Item

label

Computer-aided design of multi ...... in neurodegenerative diseases.

@en

Computer-aided design of multi ...... in neurodegenerative diseases.

@nl

prefLabel

Computer-aided design of multi ...... in neurodegenerative diseases.

@en

Computer-aided design of multi ...... in neurodegenerative diseases.

@nl

P1476

Computer-aided design of multi ...... in neurodegenerative diseases.

@en

P2093

Azedine Zoufir

http://www.w3.org/2001/XMLSchema#string

Cristina Val

http://www.w3.org/2001/XMLSchema#string

Fredrik Svensson

http://www.w3.org/2001/XMLSchema#string

Jhonny Azuaje

http://www.w3.org/2001/XMLSchema#string

Leen Kalash

http://www.w3.org/2001/XMLSchema#string

María I Loza

http://www.w3.org/2001/XMLSchema#string

Robert Glen

http://www.w3.org/2001/XMLSchema#string

P2860

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist

Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies

Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer Cells

Triazoloquinazolines as a novel class of phosphodiesterase 10A (PDE10A) inhibitors

Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions

Highly potent, selective, and orally active phosphodiesterase 10A inhibitors

Discovery of potent, selective, and metabolically stable 4-(pyridin-3-yl)cinnolines as novel phosphodiesterase 10A (PDE10A) inhibitors

Discovery and Optimization of a Series of Pyrimidine-Based Phosphodiesterase 10A (PDE10A) Inhibitors through Fragment Screening, Structure-Based Design, and Parallel Synthesis

Discovery of pyrazolopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia

P2888

s13321-017-0249-4

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13321-017-0249-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100115732

http://www.w3.org/2001/XMLSchema#string

P698

29290010

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

protein design

P932

5748027

http://www.w3.org/2001/XMLSchema#string